Prestige Consumer Healthcare (NYSE: PBH)

This investigation is for anyone who acquired securities in Prestige Consumer Healthcare (NYSE: PBH) prior to May 13, 2026.

The Law Offices of Howard G. Smith believes that the Company and certain of its executives violated federal law. Specifically, the Law Offices of Howard G. Smith believes that the Company misled investors regarding its financial condition. More specifically, the Law Offices of Howard G. Smith believes that the Company misled investors by telling investors that the Company had sufficient manufacturing capacity to keep up with demand when the Company lacked sufficient capacity.

On May 13, 2026, Prestige Consumer announced fourth quarter and full year 2026 earnings, including that, “for fiscal ’26, revenues decreased 4.5% organically versus the prior year” and “[t]otal company adjusted gross margin of 55.6% for the year was approximately flat to 55.8% in the prior year.” In the associated earnings call, the Company’s CEO Ron Lombardi revealed “in Q4, Clear Eyes sales were below expectations due to delayed shipments and production shutdowns ahead of line updates.” On this news, the price of the Company’s stock dropped precipitously on unusually heavy trading volume.

The Law Offices of Howard G. Smith seeks to recover damages on behalf of class members. If you acquired securities in Prestige Consumer Healthcare (NYSE: PBH) prior to May 13, 2026 you may join the lawsuit by submitting your information online, or you may call the Law Offices of Howard G. Smith and speak to Mr. Smith directly to learn how he can protect your rights.